Acquisition of advanced mass spectrometry equipment for pediatric research
Official title: ACQUISITION OF A QTRAP 7500 HYBRID QQQ/LIT MASS SPECTROMETER FOR PEDIATRIC TRANSLATIONAL RESEARCH
Funded at Baylor College of Medicine · NIH-10853915 · Data updated 2026-11-12
This study is all about using a super advanced machine to help doctors at Texas Children's Hospital better understand and treat kids' health issues by analyzing tiny molecules in their bodies more accurately and quickly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $597,985 |
| NIH project number | 1S10OD036416-01 |
| Project ID | NIH-10853915 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include pediatric patients under the age of 11 who are undergoing treatment for conditions related to cardiology, gastroenterology, or nephrology.
✕Less likely to help
Patients outside the pediatric age range or those with conditions not related to the specialties involved may not receive benefits from this research.
What this research studies
This research focuses on acquiring a state-of-the-art mass spectrometry system to enhance the analysis of small molecules in pediatric medicine. By utilizing ultrahigh-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS), the project aims to support various departments at Texas Children's Hospital in their translational research efforts. This advanced technology will allow for more accurate and efficient bioanalysis, which is crucial for understanding and treating pediatric conditions. The research will involve collaboration among multiple specialties, including cardiology, gastroenterology, and nephrology, to improve patient outcomes through better diagnostic and therapeutic strategies.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic capabilities and treatment options for children with various medical conditions.
How similar studies have gone: Previous research utilizing advanced mass spectrometry techniques has shown significant success in improving pediatric diagnostics and treatment outcomes.
Where this research is happening
-
Baylor College of Medicine
Houston, United States Active
Researchers
- Principal investigator: Horvath, Thomas Donald — Baylor College of Medicine
- Study coordinator: Horvath, Thomas Donald
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.